| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Accidental ferrous sulfate poisoning |
Causative agent (attribute) |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Intentional ferrous sulfate poisoning |
Causative agent (attribute) |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| intoxication par le sulfate ferreux d'intention indéterminée |
Causative agent (attribute) |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate adverse reaction |
Causative agent (attribute) |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Allergy to ferrous sulfate |
Causative agent (attribute) |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate overdose |
Causative agent (attribute) |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Accidental ferrous sulphate overdose |
Causative agent (attribute) |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Intentional ferrous sulfate overdose |
Causative agent (attribute) |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| surdose de sulfate ferreux d'intention indéterminée |
Causative agent (attribute) |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 60mg/5mL pediatric oral solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 300mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 150mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 325mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 116mg/mL drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 160mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 30mg/5mL pediatric oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Poisoning by ferrous sulfate |
Causative agent (attribute) |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing ferrous sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate+folic acid 150mg/500micrograms m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate+folic acid 325mg/350micrograms m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate+folic acid 160mg/400micrograms m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Accidental ferrous sulfate poisoning |
Causative agent (attribute) |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Intentional ferrous sulfate poisoning |
Causative agent (attribute) |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing ferrous sulfate and folic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing ascorbic acid and ferrous sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Allergy to ferrous sulfate |
Causative agent (attribute) |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate heptahydrate (substance) |
Is a |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate 300 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate sesquihydrate (substance) |
Is a |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate+folic acid 325mg/350micrograms prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate+folic acid 160mg/400micrograms prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 160mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 325mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 150mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Ferrous sulfate 300 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing ferrous sulfate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ferrous sulfate 150 milligram and folic acid 500 microgram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely ferrous sulfate 150 milligram and folic acid 500 microgram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
2 |
| Ferrous sulfate heptahydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Product containing ferrous sulfate and folic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ascorbic acid and ferrous sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ferrous sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate and folic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing only ferrous sulfate and folic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate sesquihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
| Product containing precisely ferrous sulfate 116 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ferrous sulfate 116 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ferrous sulfate 150 milligram and folic acid 500 microgram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ferrous sulfate 150 milligram and folic acid 500 microgram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ferrous sulfate 125 milligram/1 milliliter conventional release oral drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely ferrous sulfate 125 milligram/1 milliliter conventional release oral drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
1 |
| Ferrous sulfate anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ferrous sulfate (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]